Citation
Gomez Casado, Cristina and Garrido Arandia, M. and Gamboa, P.M. and Blanca-López, N. and Canto, G. and Varela, J. and Cuesta-Herranz, Javier and Pacios, Luis F. and Díaz Perales, Araceli and Tordesillas Villuendas, Leticia
(2013).
Allergenic Characterization of New Mutant Forms of Pru p 3 as New Immunotherapy Vaccines..
"Clinical & Developmental Immunology", v. 2013
;
pp..
ISSN 1740-2522.
https://doi.org/10.1155/2013/385615.
Abstract
Nowadays, treatment of food allergy only considered the avoidance of the specific food. However, the possibility of cross-reactivity makes this practice not very effective. Immunotherapy may exhibit as a good alternative to food allergy treatment. The use of hypoallergenic molecules with reduced IgE binding capacity but with ability to stimulate the immune system is a promising tool which could be developed for immunotherapy. In this study, three mutants of Pru p 3, the principal allergen of peach, were produced based on the described mimotope and T cell epitopes, by changing the specific residues to alanine, named as Pru p 3.01, Pru p 3.02, and Pru p 3.03. Pru p 3.01 showed very similar allergenic activity as the wild type by in vitro assays. However, Pru p 3.02 and Pru p 3.03 presented reduced IgE binding with respect to the native form, by in vitro, ex vivo, and in vivo assays. In addition, Pru p 3.03 had affected the IgG4 binding capacity and presented a random circular dichroism, which was reflected in the nonrecognition by specific antibodies anti-Pru p 3. Nevertheless, both Pru p 3.02 and Pru p 3.03 maintained the binding to IgG1 and their ability to activate T lymphocytes. Thus, Pru p 3.02 and Pru p 3.03 could be good candidates for potential immunotherapy in peach-allergic patients.